WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus ...

Revvity Stock Down 1.8 % RVTY stock opened at $93.79 on Thursday. The firm has a market capitalization of $11.27 billion, a PE ratio of 42.44, a PEG ratio of 3.82 and a beta of 1.07. The company ...